Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Pharmacology and Therapeutics|March 20, 2020
Population Analysis of Anidulafungin in Infants to Older Adults With Confirmed or Suspected Invasive CandidiasisRujia Xie, Lynn McFadyen, Susan Raber, et al.
The Pediatric Infectious Disease Journal|February 8, 2020
Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including CandidemiaEmmanuel Roilides, Fabianne Carlesse, Margaret Tawadrous, et al.
BMC Infectious Diseases|February 25, 2014
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trialJose Vazquez, Annette C Reboli, Peter G Pappas, et al.
The Journal of Biological Chemistry|October 29, 2013
The yeast anaerobic response element AR1b regulates aerobic antifungal drug-dependent sterol gene expressionChristina Gallo-Ebert, Melissa Donigan, Hsing-Yin Liu, et al.
Plant Physiology|August 19, 2011
A large-scale genetic screen in Arabidopsis to identify genes involved in pollen exine productionAnna A Dobritsa, Aliza Geanconteri, Jay Shrestha, et al.
The Journal of Biological Chemistry|April 20, 2002
Peptides identify the critical hotspots involved in the biological activation of the insulin receptorRenuka C Pillutla, Ku-chuan Hsiao, James R Beasley, et al.
The Journal of Antimicrobial Chemotherapy|May 2, 2017
Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trialsBart Jan Kullberg, José Vasquez, Piroon Mootsikapun, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 6, 2018
Reducing Door-to-Needle Times for Ischaemic Stroke to a Median of 30 Minutes at a Community HospitalNoreen Kamal, Elaine Shand, Robert Swanson, et al.
Bioorganic & Medicinal Chemistry|December 27, 2005
Synthesis, biological evaluation, and pharmacokinetic study of prolyl-1-piperazinylacetic acid and prolyl-4-piperidinylacetic acid derivatives as VLA-4 antagonistsJun Chiba, Gensuke Takayama, Tohru Takashi, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonistJun Chiba, Nobuo Machinaga, Tohru Takashi, et al.
Pageof 4